(Q41394569)

30 September 2017

title

The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy (English)

1 reference

30 September 2017

1 reference

2

P H Duesberg

1 reference

30 September 2017

D T Chiu

1

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

30 September 2017

1 reference

30 September 2017

volume

95

1 reference

30 September 2017

issue

1-3

1 reference

30 September 2017

page(s)

103-109

1 reference

Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM).

30 September 2017

cites work

1 reference

12 December 2020

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells

1 reference

12 December 2020

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

12 December 2020

Zidovudine and bone marrow

1 reference

12 December 2020

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

1 reference

12 December 2020

Anti-HIV drugs: comparative toxicities in murine fetal liver and bone marrow erythroid progenitor cells

1 reference

12 December 2020

Hepatomegaly with severe steatosis in HIV-seropositive patients

1 reference

12 December 2020

1 reference

12 December 2020

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study

1 reference

12 December 2020

Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds

1 reference

12 December 2020

Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group

1 reference

12 December 2020

Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers

1 reference

12 December 2020

Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future

1 reference

12 December 2020

Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction

1 reference

12 December 2020

A radiological study of cell-virus interaction in the Rous sarcoma

1 reference

12 December 2020

In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus

1 reference

12 December 2020

AIDS acquired by drug consumption and other noncontagious risk factors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01435004

1 reference

30 September 2017

1 reference